Talon Capital Corp.
TLNCNasdaqFinancials · Blank Checks · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | |
|---|---|
| Revenue | — |
| Operating income | −$546,385 |
| Net income | $2.6M |
| Total assets | $255.1M |
| Total liabilities | $10.3M |
| Equity | −$7.2M |
| EPS (diluted) | — |
| Shares out. | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −36.3%
- Return on assets
- 1.0%
- Return on capital (ROCE)
- −0.2%
- Liabilities / assets
- 4.0%
- Debt / equity
- —
- Book value / share
- —
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.77distress
- Accruals / assets
- 1.2%clean
- Piotroski F-Score
- 1/3weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 13,719 | 1.0 | -1.3% |
| Apr 30, 2026 | 13,900 | 14.6 | -7.1% |
| Apr 15, 2026 | 14,967 | 23.2 | +7.6% |
| Mar 31, 2026 | 13,907 | 1.0 | +3.9% |
| Mar 13, 2026 | 13,386 | 19.7 | -0.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Other material eventSep 16, 2025
- Entered a material agreement · Unregistered equity sale · Director / officer change · Amended charter or bylaws · Other material eventSep 12, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QQUARTERLY REPORTMay 14, 2026
- 10-K/AAMENDMENT NO.1 TO FORM 10-KApr 1, 2026
- 10-KANNUAL REPORTMar 27, 2026
- SCHEDULE 13G/AFeb 13, 2026
- 10-QQUARTERLY REPORTNov 14, 2025
- SCHEDULE 13GNov 14, 2025
- SCHEDULE 13GNov 14, 2025
- SCHEDULE 13GNov 13, 2025
- SCHEDULE 13GNov 13, 2025
- 10-QQUARTERLY REPORTOct 22, 2025
- SCHEDULE 13DSep 23, 2025
- SCHEDULE 13GSep 18, 2025
- 4Sep 16, 2025
- 4Sep 16, 2025
- 8-KCURRENT REPORTSep 16, 2025